Cardiac sarcoidosis: A retrospective study of 41 cases

Medicine

Volumn 83, Issue 6, 2004, Pages 315-334

  Chapelon Abric, Catherine ^a   De Zuttere, Dominique ^b   Duhaut, Pierre ^a   Veyssier, Pierre ^c   Wechsler, Bertrand ^a   Huong, Du Le Thi ^a   De Gennes, Christian ^a   Papo, Thomas ^a   Blétry, Olivier ^d   Godeau, Pierre ^a   Piette, Jean Charles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Serv Physiol Explorations F   (France)

^c Centre Hospitalier Compiegne   (France)

^d FOCH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METHYLPREDNISOLONE; PREDNISONE; THALLIUM 201;

ADULT; AGED; AORTA ARCH SYNDROME; ARTICLE; BONE NECROSIS; BRAIN INFARCTION; CARDIOMYOPATHY; CATARACT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG RESPONSE; ELECTROCARDIOGRAM; FAINTNESS; FEMALE; FOLLOW UP; HEART FUNCTION; HEART SARCOIDOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; LABORATORY TEST; LIVER TOXICITY; LYMPHOMA; MALE; MYOCARDITIS; OBESITY; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCINTISCANNING; SUDDEN DEATH; SYNCOPE; THORAX PAIN; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ALKALINE PHOSPHATASE; BIOPSY; BLOOD CELL COUNT; BLOOD SEDIMENTATION; CARDIOMYOPATHIES; CARDIOVASCULAR AGENTS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERCALCEMIA; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; RETROSPECTIVE STUDIES; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 9144265176     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000145367.17934.75     Document Type: Article

References (148)

1. Abeler V. Sarcoidosis of the cardiac conducting system. Am Heart J. 1979;97:701-707.
2. Angomachalelis N, Hourzamanis A, Vamvalis C, Gavrielides A. Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic sarcoidosis. Postgrad Med J. 1992; 68:S52-S56.
3. Angomachalelis N, Hourzamanis A, Salem N, Vakalis D, Serasli E, Efthimiadis T, Triantaphyllon I. Pericardial effusion concomitant with specific heart muscle disease in systemic sarcoidosis. Postgrad Med J. 1994;70(Suppl 1):S8-S12.
4. Anzai H, Momiyama Y, Kimura M. Cardiac sarcoidosis complicated by multivessel coronary spasm: a case report. J Cardiol. 1999;34:85-91.
5. Arunabh S, Verma N, Brady TM. Massive pericardial effusion in sarcoidosis. Am Fam Physician. 1998;58:660-662.
6. Auger G, Michenet P, Cami M, Kerdraon R. [Sudden death in an adult and detection of a cardiac site sarcoidosis.] Ann Med Interne (Paris). 1993;144:212-213.
7. Badorff C, Schwimmbeck PL, Kuhl U, Gerhold M, Stein H, Schultheiss HP. [Cardiac sarcoidosis: diagnostic validation by endomyocardial biopsy and therapy with corticosteroids.] Z Kardiol. 1997;86:9-14.
8. Bajaj AK, Kopelman HA, Echt DS. Cardiac sarcoidosis with sudden death: treatment with automatic implantable cardioverter defibrillator. Am Heart J. 1988;116:557-560.
9. Bashour FA, McConnell T, Skinner W, Manson M. Myocardial sarcoidosis disease. Chest. 1968;53:413-420.
10. Becker D, Berger E, Chmielewski C. Cardiac sarcoidosis: a report of four cases with ventricular tachycardia. J Cardiovasc Electrophysiol. 1990;1:214-219.
11. Bertola G, Torchio G, Meregalli M, Sironi C, Benvenuto M. [Heart sarcoidosis. A case of mitral and ascending aorta involvement.] Recenti Prog Med. 1993;84:765-767.
12. Blanc JJ, Guillerm D, Boschat J, Clavier J, Kerbrat G, Penther PH. [Sinus node function and atrioventricular conduction in 20 cases of sarcoidosis.] Arch Mal Coeur Vaiss. 1982;75:47-56.
13. Bohle W, Schaefer HE. Predominant myocardial sarcoidosis. Pathol Res Pract. 1994;190:212-217.
14. Burstow DJ, Tajik AJ, Bailey KR, De Remee RA, Taliercio CP. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol. 1989;63:478-482.
15. Case Records of the Massachusetts General Hospital (case 34-1985). N Engl J Med. 1985;313:498-509.
16. Case Records of the Massachusetts General Hospital (case 16-1995). N Engl J Med. 1995;332:1432-1439.
17. Chandra M, Silverman ME, Oshinski J, Pettigrew R. Diagnosis of cardiac sarcoidosis aided by MRI. Chest. 1996;110:562-565.
18. Chapelon C, Uzzan B, Piette JC, Jacques C, Coche C, Godeau P. [Sarcoidosis in internal medicine. A cooperative study of 554 cases.] Ann Med Interne (Paris). 1984;135:125-131.
19. Chapelon C, Piette JC, Uzzan B, Coche E, Herson S, Ziza JM, Godeau P. [The advantages of histological samples in sarcoidosis. Retrospective multicenter analysis of 618 biopsies performed on 416 patients.] Rev Med Interne. 1987;8:181-185.
20. Chapelon C, Ziza JM, Piette JC, Levy Y, Raguin G, Wechsler B, Bitker MO, Bletry O, Laplane D, Bousser MG, Godeau P. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore). 1990;69:261-276.
21. Chapelon-Abric C, Lascault G, De Gennes C, Godeau P. [Cardiac sarcoidosis. A case of sinoatrial block.] Presse Med. 1995;24:370.
22. Chapelon-Abric C. [Cardiac sarcoidosis.] Ann Med Interne (Paris). 2001;152:125-133.
23. Chin BB, Civelek AC, Mudun A. Resting TI-201 scintigraphy in the evaluation of myocardial sarcoidosis. Clin Nuclear Med. 1997;22:475-478.
24. Delacretaz E, Stevenson WG, Winters GL. Ablation of ventricular tachycardia with a saline-cooled radiofrequency catheter: anatomic and histologic characteristics of the lesions in humans. J Cardiovasc Electrophysiol. 1999;10:860-865.
25. Demeter SL. Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide. Chest. 1988;94:202-203.
26. Diderholm E, Eklund A, Orinius E, Widstrom O. Exudative pericarditis in sarcoidosis. A case report and echocardiographic study. Sarcoidosis. 1989;6:60-62.
27. Doherty MJ, Kumar SK, Nicholson AA, McGivern DV. Cardiac sarcoidosis: the value of magnetic resonance imaging in diagnosis and assessement of response to treatment. Respir Med. 1998;92:697-699.
28. Drui S, Brandt CM, Neiman JL, Fincker JL. [Cardiac sarcoidosis. Mechanisms of valvular dysfunctions.] Sem Hop. 1983;59:195-197.
29. Dupuis JM, Victor J, Furber A, Pezard P, Lejeune LL, Tadei A. [Value of magnetic resonance imaging in cardiac sarcoidosis. Apropos of a case.] Arch Mal Coeur Vaiss. 1994;87:105-110.
30. Eguchi M, Tsuchihashi K, Hotta D, Hashimoto A, Sasao H, Yuda S, Nakata T, Shijubou N, Abe S, Shimamoto K. Technetium-99m sestamibi/tetrofosmin myocardial perfusion scanning in cardiac and noncardiac sarcoidosis. Cardiology. 2000;94:193-199.
31. Eliasch H, Juhlin-Dannfelt A, Sjogren I, Terent A. Magnetic resonance imaging as an aid to the diagnosis and evaluation of suspected myocardial sarcoidosis in a fighter pilot. Aviat Space Environ Med. 1995;66:1010-1013.
32. Fahy GJ, Marwick T, McCreery CJ, Quigley PJ, Maurer BJ. Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest. 1996;109:62-66.
33. Fields CL, Ossorio MA, Roy TM, Denny DM, Varga DW. Thallium-201 scintigraphy in the diagnosis and management of myocardial sarcoidosis. South Med J. 1990;83:339-342.
34. Fleming HA. Sarcoid heart disease. Br Heart J. 1974;36:54-68.
35. Fleming HA. Sarcoid heart disease. Br Heart J. 1983;50:498.
36. Fleming HA. Death from sarcoid heart disease. United Kingdom series 1971-1986. 300 cases with 138 deaths. In: Grassi G. Rizzato G, Pozzi E, eds. Sarcoidosis and Other Granulomatous Disorders: Proceedings of the 11th World Congress on Sarcoidosis and Other Granulomatous Disorders. Amsterdam: Elsevier; 1988:19-33.
37. Forman MB, Sandler MP, Sacks GA, Kronenberg MW, Powers TA. Radionuclide imaging in myocardial sarcoidosis. Demonstration of myocardial uptake of technetium pyrophosphate99m and gallium. Chest. 1983;83:578-580.
38. Fujita N, Hiroe M, Suzuki Y, Sato H, Inoue Y, Sekiguchi M, Hosoda S. A case with cardiac sarcoidosis. Significance of the effect of steroids on the reversion of advanced atrioventricular block and myocardial scintigraphic abnormalities. Heart Vessels Suppl. 1990;5:16-18.
39. Fukuhara T, Morini M, Sakoda S, Bito K, Kinoshita M, Kawakita S. Myocarditis with multinucleated giant cells detected in biopsy specimens. Clin Cardiol. 1988;11:341-344.
40. Fuse K, Kodama M, Okura Y, Ito M, Aoki Y, Hirono S, Kato K, Hanawa H, Aizawa Y. Levels of serum interleukin-10 reflect disease activity in patients with cardiac sarcoidosis. Jpn Circ J. 2000;64:755-759.
41. Gibbons WJ, Levy RD, Nava S, Malcolm J, Marin JM, Tardif C, Magder C, Lisbona R, Cosio MG. Subclinical cardiac dysfunction in sarcoidosis. Chest. 1991;100:44-50.
42. Godeau P, Chapelon-Abric C. [Sarcoidosis symptomatic cardiomyopathy: report of 10 cases.] Bull Acad Natl Med. 1996;180:2005-2018.
43. Gori F, Taddei GL, Pedemonte E, Ciaccheri M. [Sarcoidosis with predominant cardiac involvement.] Cardiologica. 1997;42:421-423.
44. Gozo EG, Cosnow I, Cohen HC, Okun L. The heart in sarcoidosis. Chest. 1971;60:379-388.
45. Grollier G, Galateau F, Scanu P, Commeau P, Voglimacci M, Bernard JP, Khayat A, Potier JC. [Cardiac sarcoidosis responsible for localized left ventricular ectasia and refractory ventricular tachycardia. Anatomoclinical study.] Arch Mal Coeur Vaiss. 1990;83:561-564.
46. Hermosilla Cabrerizo T, Rodrigo Trallero G, Suarez Alzamora J, Pelegrin Diaz J, Zabala Lopez S, Diez Manglano J, Bueno Gmez J. [Myocardial sarcoidosis treated with implantable defibrillator.] An Med Interna. 1991;8:338-340.
47. Hillerdal O, Niou E, Osterman K. Sarcoidosis. Epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis. 1984;130:29-32.
48. Hirose Y, Ishida Y, Hayashida K, Maeno M, Takamiya M, Ohmori F, Miyatake K, Uehara T, Nishimura T, Tachibana T. Myocardial involvement in patients with sarcoidosis. An analysis of 75 patients. Clin Nucl Med. 1994;19:522-526.
49. Huang PL, Brooks R, Carpenter CH, Garan H. Antiarrhythmic therapy guided by programmed electrical stimulation in cardiac sarcoidosis with ventricular tachycardia. Am Heart J. 1991;121:599-601.
50. Ishikawa T, Kondoh H, Nakagawa S, Koiwaya Y, Tanaka K. Steroid therapy in sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisone. Chest. 1984;85:445-447.
51. Israel RH, Poe RH. Massive pericardial effusion in sarcoidosis. Respiration. 1994;61:176-180.
52. Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 1993;43:372-376.
53. Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP, Maheshwari A, Noguchi TI. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis. 1994;11:26-31.
54. Jain A, Starek PJ, Delany DL. Ventricular tachycardia and ventricular aneurysm due to unrecognized sarcoidosis. Clin Cardiol. 1990;13: 738-740.
55. James DJ, Turiaf J, Hosoda YY. Description of sarcoidosis: report of the subcommittee on classification and definition. In: Siltzbach LE, ed. Seventh International Conference of Sarcoidosis and Other Ganulomatous Disorders. New York: New York Academy of Sciences; 1976:742.
56. Joffe II, Lampert C, Jacobs LE, Owen AN, Ioli A, Kotler MN. Cardiac sarcoidosis masquerading as a metastatic tumor: the role of transthoracic and transesophageal echocardiography. J Am Soc Echocardiogr. 1995;8: 933-937.
57. Johns CJ, Paz H, Kasper EK, Baughman K. Myocardial sarcoidosis: course and management. Sarcoidosis. 1992;9(Suppl):231-236.
58. Kasai H, Suzuki J, Imamura H, Yazaki Y, Isobe M, Sekiguchi M. A case of cardiac sarcoidosis with advanced atrioventricular block. Failure of endomyocardial biopsy diagnosis and success in detecting. Heart Vessels. 2003;18:50-52.
59. Kato Y, Morimoto S, Uemura A, Hiramitsu S, Ito T, Hishida H. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:133-137.
60. Kawamura Y, Yoshida A, Toyoshima E, Sato N, Kawashima E, Hasebe N, Kikuchi K, Matsuhashi H. A case of cardiac sarcoidosis: significance of ventricular tachycardia originating from the septum. Jpn Circ J. 1998;62:458-461.
61. Kinney EL, Jackson GL, Reeves WX, Zelis R. Thallium-scan myocardial defects and echocardiographic abnormalities in patients with sarcoidosis without clinical cardiac dysfunction. An analysis of 44 patients. Am J Med. 1980;68:497-503.
62. Kinney E, Murthy R, Ascunge GL, Donohoe R. Pericardial effusion in sarcoidosis. Chest. 1979;76:476-478.
63. Knapp WH, Bentrup A, Ohlmeier H. Indium 111-labelled antimyosin antibody imaging in a patient with sarcoidosis. Eur J Nucl Med. 1993; 20:80-82.
64. Kollermann J, Roos G, Helpap B. Sudden cardiac death from unrecognized cardiac sarcoidosis. Pathology. 2001;22:141-144.
65. Kurata C, Sakata K, Taguchi T. SPECT imaging with TI-201 and Ga-67 in myocardial sarcoidosis. Clin Nucl Med. 1990;15:408.
66. Lanfranchi J, Battesti JP, Habbas JP, d'Angeli JL. [Electrocardiographic anomalies in mediastino-pulmonary sarcoidosis without cor pulmonale.] Rev Med Interne. 1980;1:105-111.
67. LeGuludec D, Menad F, Faraggi M, Weinmann P, Battesti JP, Valeyre D. Myocardial sarcoidosis: clinical value of technetium-99m sestamibi tomoscintigraphy. Chest. 1994;106:1675-1682.
68. Lemery R, McGoon MD, Edwards WD. Cardiac sarcoidosis: a potentially treatable form of myocarditis. Mayo Clin Proc. 1985;60: 549-554.
69. Lewin RF. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J. 1985;110:116-122.
70. Lip GYH, Gupta J, Gill JS, Singh SP. Sarcoid heart disease: a rare cause of chest pain and malignant cardiac arrhythmia in a young Asian man. Angiology. 1996;47:905-910.
71. Lorell B, Alderman EL, Mason JW. Cardiac sarcoidosis: diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol. 1978;42:143-146.
72. Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med. 1995;50:555-559.
73. Ludmerer KM, Kissane JM. Refractory ventricular arrhythmias and death in a 43-year old man. Am J Med. 1990;89:496-506.
74. Lull RJ, Dunn BE, Gregoratos G, Cox WA, Fisher GW. Ventricular aneurysm due to cardiac sarcoidosis with surgical cure of refractory ventricular tachycardia. Am J Cardiol. 1972;30:282-287.
75. Mafart B, Talard P, Bouchiat C, Chagnon A. [Does corticosteroid therapy favor the development of ventricular aneurysm in myocardial sarcoidosis?] Arch Mal Coeur Vaiss. 1991;84:1489.
76. Mana J. Nuclear imaging. 67Gallium, 201thallium, 18F-labeled fluoro2-deoxy-D-glucose positron emission tomography. Clin Chest Med. 1997;18:799-811.
77. Matsui Y, Iwai K, Tachibana T, Fruie T, Shigematsu N, Izumi T, Homma AH, Mikami R, Hongo O, Hiraga Y, Yamamoto M. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci. 1976;278:455-469.
78. Matsumori A, Hara M, Nagai S, Izumi T, Ohashi N, Ono K, Sasayama S. Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis. Jpn Circ J. 2000;64:679-683.
79. Mayock RL, Bertrand DP, Morrison CE, Scott JH. Manifestations of sarcoidosis. Analysis of 145 patients with a review of nine series selected from the literature. Am J Med. 1963;35:67-89.
80. Mazzone P, Arroliga AC. Acute dyspnea and hypoxia in a 37-year-old woman with sarcoidosis. Chest. 1998;113:830-833.
81. McDougall NI, Purvis JA, Wilson CM, Adgey AA. Asystolic arrest as a presentation of sarcoidosis. Int J Cardiol. 1994;47:165-167.
82. Messas E, Charniot JC, Lanfranchi J, Battesti JP, Weinman P, Zerhouni K, Gallot D, Artigou JY. [Cardiogenic shock presenting a cardiac sarcoidosis. A propos of a case.] Arch Mal Coeur Vaiss. 1998;91:771-776.
83. Meyer A, Schafer H, Doring V, Maisch B, Kirsten D. [Heart transplantation in myocardial sarcoidosis. Studies on the explanted heart.] Dtsch Med Wochenschr 1999;124:1131-1134.
84. Misumi I, Kimura Y, Hokamura Y, Honda Y, Yasunaga T, Nakashima K, Takemura N, Asoshina M, Uranaka N, Takenaka S, Shima K. Scintigraphic detection of regional disruption of adrenergic nervous system in sarcoid heart disease. Jpn Circ J. 1996;60:774-778.
85. Naruse TK, Matsuzawa Y, Ota M, Katsuyama Y, Matsumori A, Hara M, Nagai S, Morimoto S, Sasayama S, Inoko H. HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens. 2000;56:52-57.
86. Numao Y, Sekiguchi M, Furuie T, Matsui Y, Izumi T, Mikami R. A study of cardiac involvement in 963 cases of sarcoidosis by ECG and endomyocardial biopsy. In: Jones Williams B, Davies BH, eds. 8th International Conference on Sarcoidosis and Other Granulomatous Diseases. 1978. Cardiff, Wales: Alpha Omega Publishing; 1980: 607-614.
87. Okamoto M, Hashimoto M, Sueda T, Munemori M, Yamada T. Polymorphic ventricular tachycardia with cardiac sarcoidosis: treatment with low dose metoprolol and cibenzoline. Intern Med. 1994;33:296-299.
88. Okamoto H, Mizuno K, Ohtoshi E. Cutaneous sarcoidosis with cardiac involvement. Eur J Dermatol. 1999;9:466-469.
89. Okayama K, Kurata C, Tawarahara K, Wakabayashi Y, Chida K, Sato A. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest. 1995;107: 330-334.
90. Oldenburg O, Schafers RF, Kuntz S, Sack S, Erbel R, Philipp T, Weber F. [Heart failure as a cardiac symptom of sarcoidosis. Successful treatment of heart failure with steroids, digitalis and an angiotensin-1-receptor in sarcoidosis.] Med Klin (Munich). 2000;95:151-157.
91. Oni AA, Hershberger RE, Norman DJ, Ray J, Hovaguimian H, Cobanoglu AM, Hosenpud JD. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant. 1992;11:367-369.
92. Ott P, Marcus FI, Sobonya F, Knight BP, Fuenzalida CP. Cardiac sarcoidosis masquerading as right ventricular dysplasia. Pacing Clin Electrophysiol. 2003;26:1498-1503.
93. Paz HL, McCormick DJ, Kutalek SP, Patchefsky A. The automated implantable cardiac defibrillator. Prophylaxis in cardiac sarcoidosis. Chest. 1994;106:1603-1607.
94. Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch Pathol Lab Med. 1995;119:167-172.
95. Porter GH. Sarcoid heart disease. N Engl J Med. 1960;263:1350-1356.
96. Ratner SJ, Fenoglio JJ, Ursell PC. Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis. Chest. 1986;90:528-533.
97. Reuhl J, Schneider M, Sievert H, Lutz FU, Zieger G. Myocardial sarcoidosis as a rare cause of sudden cardiac death. Forensic Sci Int. 1997;89:145-153.
98. Riedy K, Fisher MR, Belic N, Koenigsberg DI. MR imaging of myocardial sarcoidosis. AJR Am J Roentgenol. 1988;151:915-916.
99. Roberts WC, McAllister HA, Ferrans VJ. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients and review of 78 previously described necropsy patients. Am J Med. 1977;63: 86-108.
100. Rubinstein I, Baum GL, Hiss Y. Cardiac tamponade as the presenting symptom of sarcoidosis. Am Heart J. 1985;109:1387-1388.
101. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234-241.
102. Schaedel H, Kirsten D, Schmidt H, Strauss HJ. Sarcoid heart disease: results of follow-up investigations. Eur Heart J. 1991;12:26-27.
103. Sekiguchi M, Numao Y, Imai M, Furuie T, Mikami R. Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. II. Myocarditis. Jpn Circ J. 1980;44:264-273.
104. Sekiguchi M, Kaneko M, Hiroe M, Hirosawa K. Recent trends in cardiac sarcoidosis research in Japan. Heart Vessels Suppl. 1985;1:45-49.
105. Sekiguchi M, Yazaki Y, Isobe M, Hiroe M. Cardiac sarcoidosis: diagnostic, prognostic and therapeutic considerations. Cardiovasc Drugs Ther. 1996;10:495-510.
106. Shammas RL, Movahed A. Successful treatment of myocardial sarcoidosis with steroids. Sarcoidosis. 1994;11:37-39.
107. Sharma OP, Klatt E. Factors which adversely affect the course of sarcoidosis. In: Grassi G, Rizzato G, Pozzi E, eds. Sarcoidosis and Other Granulomatous Disorders: Proceedings of the 11th World Congress on Sarcoidosis and Other Granulomatous Disorders. Amsterdam: Elsevier; 1988:421-422.
108. Shiff AD, Blatt CJ, Colp C. Recurrent pericardial effusion secondary to sarcoidosis of the pericardium: a biopsy proved case. N Engl J Med. 1969;281:141-143.
109. Shimada T, Shimada K, Sakane T, Ochiai K, Tsukihashi H, Fukui M, Inoue S, Katoh H, Murakami Y, Ishibashi Y, Maruyama R. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med. 2001;110:591-592.
110. Shimazu A, Ishikura Y, Odagiri S, Hashimoto M, Hirao D, Shirakusa T. [A case of mitral stenosis associated with cardiac sarcoidosis and left ventricular aneurysm.] Nippon Kyobu Geka Gakkai Zasshi. 1991; 39:952-955.
111. Shindo T, Kurihara H, Ohishi N, Morita H, Maemua K, Kurihara Y, Tsuneyoshi H, Chi H, Yamaski K, Yazaki Y. Cardiac sarcoidosis. Circulation. 1998;97:1306-1307.
112. Shiotani H, Miyazaki T, Matsunaga M, Kado T. Improvement of severe heart failure with corticosteroid therapy in a patient with myocardial sarcoidosis. Jpn Circ J. 1991;55:393-396.
113. Shiraishi J, Tatsumi T, Shimoo K, Katsume A, Mani H, Kobara M, Shirayama T, Azuma A, Nakagawa M. Cardiac sarcoidosis mimicking right ventricular dysplasia. Circ J. 2003;67:169-171.
114. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58:1204-1211.
115. Skold CM, Larsen FF, Rasmussen E, Pehrsson SK, Eklund AG. Determination of cardiac involvement in sarcoidosis by magnetic resonance imaging and doppler echocardiography. J Intern Med. 2002; 252:465-467.
116. Stein E, Jackler I, Stimmel B. Asymptomatic electrocardiographic alterations in sarcoidosis. Am Heart J. 1973;86:474-477.
117. Stewart RE, Graham DM, Godfrey GW, Friedman HZ, Das SK, Shea MJ. Rapidly progressive heart failure resulting from cardiac sarcoidosis. Am Heart J. 1988;115:1324-1326.
118. Studdy RP, Lapworth R, Bird R. Angiotensin-converting enzyme and its clinical significance: a review. J Clin Pathol. 1983;36:938-947.
119. Suzuki T, Kanda T, Kubota S, Imai S, Murata K. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest. 1994;106:1021-1024.
120. Takada K, Ina Y, Yamamoto M, Satoh T, Morishita M. Prognosis after pacemaker implantation in cardiac sarcoidosis in Japan. Clinical evaluation of corticosteroid therapy. Sarcoidosis. 1994;11:113-117.
121. Takahashi T, Fukuta S, Date T, Hamamoto T, Yoshinaga T, Kohtoku S, Ono S, Matsuzaki M, Kusukawa R. An autopsy case of cardiac sarcoidosis with refractory ventricular tachycardia. Heart Vessels Suppl. 1990;5:13-15.
122. Takashige N, Naruse TK, Matsumori A, Hara M, Nagai S, Morimoto S, Hiramitsu S, Sasayama S, Inoko H. Genetic polymorphisms at the tumor necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens. 1999;54:191-193.
123. Taki J, Nakajima K, Bunko H, Ohguchi M, Jonami N, Hisada K. Cardiac sarcoidosis demonstrated by T1-201 and Ga-67 SPECT imaging. Clin Nucl Med. 1990;15:636.
124. Tan LB, Dickie S, McKenna WJ. Left ventricular diastolic characteristics of cardiac sarcoidosis. Am J Cardiol. 1986;58:1126-1127.
125. Tawarahara K, Kurata C, Okayama K, Kobayashi A, Yamazaki N. Thallium-201 and gallium 67 single photon emission computed tomographic imaging in cardiac sarcoidosis. Am Heart J. 1992;124:1383-1384.
126. Tellier P, Paycha F, Antony I, Nitenberg A, Valeyre D, Foult JM, Battesti JP. Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med. 1988;85: 189-193.
127. Ueda M, Fujimoto T, Shoji S, Nagao M, Sorachi K, Ito T. Cardiac sarcoidosis. Jpn Heart J. 1990;31:251-258.
128. Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999;138:299-302.
129. Umetani K, Ishihara T, Yamamoto K, Sawanobori T, Kohno I, Ijiri H, Komori S, Tamura K. Successfully treated complete atrioventricular block with corticosteroid in a patient with cardiac sarcoidosis: usefulness of gallium-67 and thallium-201 scintigraphy. Intern Med. 2000;39:245-248.
130. Valantine HA, Tazelaar HD, Macoviak J, Mullin AV, Hunt SA, Feuler MB, Bellingham ME, Schroeder JS. Cardiac sarcoidosis: response to steroids and transplantation. J Heart Transplant. 1987;6: 244-250.
131. Veinot JP, Johnston B. Cardiac sarcoidosis, an occult cause of sudden death: a case report and literature review. J Forensic Sci. 1998;43: 715-717.
132. Verkleeren JL, Glover MU, Bloor C, Joswig BC. Cardiac tamponade secondary to sarcoidosis. Am Heart J. 1983;106:601-603.
133. Vignaux O, Dhote R, Duboc D, Blanche P, Dusser D, Weber S, Legmann P. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest. 2002;122:1895-1901.
134. Virmani R, Bures C, Roberts WC. Cardiac sarcoidosis. A major cause of sudden death in young individuals. Chest. 1980;77:423-428.
135. Wait JL, Movahed A. Anginal chest pain in sarcoidosis. Thorax. 1989; 44:391-395.
136. Wallaert B, Ramon PH, Fournier E. Bronchoalveolar lavage, serum angiotensin converting enzyme and gallium 67 scanning in extrathoracic sarcoidosis. Chest. 1992;83:553-555.
137. Walsh MJ. Systemic sarcoidisis with refractory ventricular tachycardia and heart failure. Br Heart J. 1978;40:931-933.
138. Watson J, Smith V, Schmidt D, Navratil D. Automatic implantable cardioverter-defibrillator: early experience at Wilford Hall USAF Medical Center. South Med J. 1992;85:161-163.
139. Winters SL, Cohen M, Greenberg S, Stein B, Curwin J, Pe E, Gomes JA. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol. 1991;18: 937-943.
140. Wynne JW, Ryerson GG, Dalovisio J. Myocardial sarcoidosis complicated by mural thrombosis. Thorax. 1979;34:127-129.
141. Yamaguchi J, Shikano Y, Sato S, Shimamoto K. [A clinical and pathological study of 46 cases of sudden and unexpected death.] Nippon Ronen Igakkai Zasshi. 1995;32:722-727.
142. Yamamoto N, Goth K, Yagi Y, Terashima Y, Nagashima K, Sawa T, Deguchi F, Nawada M, Tanaka H, Tsukamoto T. Thallium-201 myocardial SPECT findings at rest in sarcoidosis. Ann Nucl Med. 1993;7:97-103.
143. Yamamoto M, Muramatsu M, Suzuki T. Successful corticosteroid treatment of seven cases of probable myocardial sarcoid. In: Jones Williams B, Davies BH, eds. International Conference on Sarcoidosis and Other Granulomatous Diseases. Cardiff, Wales: Alpha Omega Publishing; 1980;615-623.
144. Yazaki Y, Hongo M, Hiroyoshi Y. Cardiac sarcoidosis in Japan: treatment and prognosis. In: Sekiguchi M, Ridchardson PJ, eds. Prognosis and Treatment of Cardiomyopathy and Myocarditis. Tokyo: University of Tokyo Press; 1994:351-353.
145. Yazaki Y, Isobe M, Hayasaka M, Tanaka M, Fujii T, Sekiguchi M. Cardiac sarcoidosis mimicking hypertrophic cardiomyopathy: clinical utility of radionuclide imaging for differential diagnosis. Jpn Circ J. 1998;62:465-468.
146. Yazaki Y, Isobe M, Hiramitsu S, Morimoto S, Hiroe M, Omichi C, Nakano T, Saeki M, Izumi T, Sekiguchi M. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol. 1998;82:537-540.
147. Yoshida Y, Morimoto S, Hiramitsu S, Tsuboi N, Hirayama H, Itoh T. Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J. 1997;134:382-386.
148. Zelcer AA, LeJemtel TH, Jones J, Stahl J. Pericardial tamponade in sarcoidosis. Can J Cardiol. 1987;3:12-13.